900 related articles for article (PubMed ID: 32936058)
21. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.
Wang L; Hong PJ; May C; Rehman Y; Oparin Y; Hong CJ; Hong BY; AminiLari M; Gallo L; Kaushal A; Craigie S; Couban RJ; Kum E; Shanthanna H; Price I; Upadhye S; Ware MA; Campbell F; Buchbinder R; Agoritsas T; Busse JW
BMJ; 2021 Sep; 374():n1034. PubMed ID: 34497047
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
Petzke F; Enax-Krumova EK; Häuser W
Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
[TBL] [Abstract][Full Text] [Related]
23. Cannabis-based medicines and pain: a review of potential synergistic and entourage effects.
Anand U; Pacchetti B; Anand P; Sodergren MH
Pain Manag; 2021 Apr; 11(4):395-403. PubMed ID: 33703917
[TBL] [Abstract][Full Text] [Related]
24. State of the science: cannabis and cannabinoids in palliative medicine-the potential.
Roychoudhury P; Kapoor AK; Walsh D; Cortes H; Clarke H
BMJ Support Palliat Care; 2021 Sep; 11(3):299-302. PubMed ID: 33903260
[TBL] [Abstract][Full Text] [Related]
25. [Cannabinoids for neuropathic pain management].
Andersen LØ; Enggaard TP; Højsted J
Ugeskr Laeger; 2018 Feb; 180(9):. PubMed ID: 29506645
[TBL] [Abstract][Full Text] [Related]
26. Cannabis and cannabinoids in cancer pain management.
Meng H; Dai T; Hanlon JG; Downar J; Alibhai SMH; Clarke H
Curr Opin Support Palliat Care; 2020 Jun; 14(2):87-93. PubMed ID: 32332209
[TBL] [Abstract][Full Text] [Related]
27. Medical Cannabis for Neuropathic Pain.
Lee G; Grovey B; Furnish T; Wallace M
Curr Pain Headache Rep; 2018 Feb; 22(1):8. PubMed ID: 29388063
[TBL] [Abstract][Full Text] [Related]
28. [Cannabis and cannabinoids for the treatment of acute and chronic pain].
Schäfer M; Tafelski S
Anaesthesist; 2021 Jul; 70(7):551-562. PubMed ID: 34196726
[TBL] [Abstract][Full Text] [Related]
29. Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies.
Cooper ZD; Abrams DI
Am J Drug Alcohol Abuse; 2019; 45(6):580-595. PubMed ID: 31687845
[No Abstract] [Full Text] [Related]
30. Efficacy, tolerability and safety of cannabis-based medicines for cancer pain : A systematic review with meta-analysis of randomised controlled trials.
Häuser W; Welsch P; Klose P; Radbruch L; Fitzcharles MA
Schmerz; 2019 Oct; 33(5):424-436. PubMed ID: 31073761
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoids in the treatment of rheumatic diseases: Pros and cons.
Sarzi-Puttini P; Ablin J; Trabelsi A; Fitzcharles MA; Marotto D; Häuser W
Autoimmun Rev; 2019 Dec; 18(12):102409. PubMed ID: 31648042
[TBL] [Abstract][Full Text] [Related]
32. Use of Cannabis and Cannabinoids in Patients With Cancer.
Sawtelle L; Holle LM
Ann Pharmacother; 2021 Jul; 55(7):870-890. PubMed ID: 33070617
[TBL] [Abstract][Full Text] [Related]
33. The Exploration of Cannabis and Cannabinoid Therapies for Migraine.
Chandwani B; Bradley BA; Pace A; Buse DC; Singh R; Kuruvilla D
Curr Pain Headache Rep; 2023 Sep; 27(9):339-350. PubMed ID: 37515745
[TBL] [Abstract][Full Text] [Related]
34. Clinical uses of cannabis and cannabinoids in the United States.
Levinsohn EA; Hill KP
J Neurol Sci; 2020 Apr; 411():116717. PubMed ID: 32044684
[TBL] [Abstract][Full Text] [Related]
35. Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids.
O'Brien M; McDougall JJ
Curr Opin Pharmacol; 2018 Jun; 40():104-109. PubMed ID: 29635215
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Whiting PF; Wolff RF; Deshpande S; Di Nisio M; Duffy S; Hernandez AV; Keurentjes JC; Lang S; Misso K; Ryder S; Schmidlkofer S; Westwood M; Kleijnen J
JAMA; 2015 Jun 23-30; 313(24):2456-73. PubMed ID: 26103030
[TBL] [Abstract][Full Text] [Related]
37. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
38. Medical cannabis: A forward vision for the clinician.
Fitzcharles MA; Eisenberg E
Eur J Pain; 2018 Mar; 22(3):485-491. PubMed ID: 29377381
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials.
Deshpande A; Mailis-Gagnon A; Zoheiry N; Lakha SF
Can Fam Physician; 2015 Aug; 61(8):e372-81. PubMed ID: 26505059
[TBL] [Abstract][Full Text] [Related]
40. Medical Cannabinoids in Children and Adolescents: A Systematic Review.
Wong SS; Wilens TE
Pediatrics; 2017 Nov; 140(5):. PubMed ID: 29061872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
